Smarter symptom management for children with cancer: development and
evaluation plans of a smartphone app to monitor patient-reported outcome
measures (RESPONSE)
Abstract
Background Symptoms and associated distress in children diagnosed and
treated for cancer are uniformly common, yet structured and systematic
symptom monitoring is not yet commonplace. With increasing pressures on
the healthcare workforce, improved systematic approaches to symptom
management are required. Methods Medical, nursing and allied health
oncology clinicians developed algorithms using consensus techniques to
ascertain thresholds of concern for each symptom for the Symptom
Screening in Pediatrics (SPPedi) tool, a Patient Reported Outcome
Measure (PROM). Algorithm vetting and refinement were achieved through
iterative interviews and consultation with clinicians. Self-management
evidence-based recommendations for each symptom were developed. The
algorithms were incorporated into an existing smartphone application
(MyQCH), as part of the Oncology Hub, and an iterative evaluation is
planned to test the feasibility, acceptability, safety, usefulness, and
other domains including a hybrid effectiveness trial
(ACTRN12621001084875). Discussion Digital solutions provide alternative
options for communication, information, and education and opportunities
to harness the best of community and hospital services. The Oncology Hub
and RESPONSE system is a comprehensive approach to symptom management
that includes a suite of tools and resources including a smartphone app
that collects PROMs and delivers symptom management advice, as well as
written resources for both the families of children with cancer and
clinicians. Conclusions Using technology offers new ways to think about
how clinicians and families communicate and share information.
Understanding how information is exchanged using technology, and how
this impacts clinical workflow is critical to successful implementation,
and to ultimately optimise symptom assessment management in children
with cancer.